Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katsunori Toyoda"'
Autor:
Hironari Minami, Katsunori Toyoda, Takeo Hata, Masami Nishihara, Masashi Neo, Keiichiro Nishida, Tetsufumi Kanazawa
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
BackgroundDelirium frequently affects the consciousness of the elderly, particularly those in hospitals. Evidence increasingly associates linking delirium history to an increased risk of dementia. However, most studies are limited in scope, focusing
Externí odkaz:
https://doaj.org/article/947e06660ec74d85b53674d61b25bfd2
Autor:
Yasuo Kawabata, Shin-ichi Imazu, Koichi Matsumoto, Katsunori Toyoda, Makoto Kawano, Yoichiro Kubo, Shinya Kinoshita, Yoshitaka Nishizawa, Tetsufumi Kanazawa
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Multichannel functional near-infrared spectroscopy (fNIRS) is a tool used to capture changes in cerebral blood flow. A consistent result for depression is a decrease in blood flow in the frontal cortex leading to hypofrontality, which indicates multi
Externí odkaz:
https://doaj.org/article/3297b21cfcd643b5b2a171cbd04f634e
Autor:
Takeo Hata, Yoichiro Kubo, Masami Nishihara, Katsunori Toyoda, Shigeru Yamauchi, Tetsufumi Kanazawa, Shinya Kinoshita, Ken Inada, Shinichi Imazu
Publikováno v:
Journal of Psychiatric Research. 141:116-123
Clozapine is the only effective antipsychotic drug used for the treatment of treatment-resistant schizophrenia. Although it has been shown that the frequency of clozapine use is very low in Japan, our previous study revealed that the number of clozap
Autor:
Katsunori Toyoda, Shigeru Yamauchi, Tetsufumi Kanazawa, Kazuhisa Uchiyama, Takeo Hata, Ken Inada, Masami Nishihara, Shinya Kinoshita
Publikováno v:
Psychiatry Investigation
Objective The effectiveness of clozapine is clearly superior to other antipsychotics in the treatment of refractory schizophrenia. Clozapine leads to various side effects, and therefore many patients are forced to discontinue. In this study, we analy
Autor:
Tetsufumi Kanazawa, Munehiro Ohta, Tatsushi Okayama, Yumi Tamura, Norio Yasui-Furukori, Takehiko Okamura, Seiichiro Tarutani, Hiroshi Yoneda, Katsunori Toyoda, Hiroki Kikuyama
Publikováno v:
Clinical Neuropsychopharmacology and Therapeutics. 7:36-40